A young female patient with massive LVH and dual-level obstructive HCM: a case report on the successful use of mavacamten and future management planning

28 August 2026 (10:57 - 11:09)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Debora Da Silva Correia

Hospital Santa Cruz, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail

Early haemodynamic response but persistent systolic dysfunction after mavacamten interruption in obstructive hypertrophic cardiomyopathy (oHCM): a pharmacist led titration case

Miss D. Lakhani (London, GB)

Presentation thumbnail

Unusual genetics in hypertrophic cardiomyopathy: looking beyond autosomal dominant inheritance

Doctor S. Rivas Garcia (Madrid, ES)

Presentation thumbnail

Hypertrophic cardiomyopathy phenotype associated with concomitant gla, ttr and prkag2 variants in an amazonian adolescent

Doctor I. Peterlini Valsi (Sao Paulo, BR)

Presentation thumbnail

Mavacamten for worsening left ventricular outflow tract obstruction after TAVI in a patient with hypertrophic cardiomyopathy

Mr M. Takeuchi (Nankoku, JP)

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: from diagnosis to therapy

The Event

Event poster

ESC Congress 2026

28 August 2026 10:57 CET

You may be interested in

Congress Session

Hypertrophic cardiomyopathy (HCM) summit: navigating patient cases

30 August 2024

Congress Presentation

Case: challenging choice between CMIs and surgery

17 May 2025

Congress Session

Cardiomyopathies cases

11 December 2025

Congress Presentation

A new era in drug treatment for hypertrophic obstructive cardiomyopathy

12 May 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources